Insulet has had its first success in its legal dispute with the South Korea-based EOFlow, which it has accused of patent infringement.
Insulet is claiming that when it examined EOFlow’s EOPatch, similarities between EOPatch and its own Omnipod products were apparent.
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?